Provided by Tiger Trade Technology Pte. Ltd.

XILIO THERAPEUTICS, INC.

8.29
-0.0600-0.72%
Volume:15.35K
Turnover:128.78K
Market Cap:49.60M
PE:-1.53
High:8.47
Open:8.47
Low:8.29
Close:8.35
52wk High:16.10
52wk Low:6.47
Shares:5.98M
Float Shares:3.65M
Volume Ratio:1.14
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.4128
EPS(LYR):-15.2374
ROE:-75.20%
ROA:-19.76%
PB:0.68
PE(LYR):-0.54

Loading ...

Xilio Therapeutics files $250M mixed securities shelf

TIPRANKS
·
May 13

Xilio Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 12

Xilio Therapeutics Inc - May Offer up to $17.22 Mln Common Stock Under Sales Agreement With Leerink Partners - SEC Filing

THOMSON REUTERS
·
May 12

Press Release: Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Dow Jones
·
May 12

Xilio Therapeutics grants new hire stock options for 1,982 shares at $8.32 each

Reuters
·
May 08

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 08

Xilio Therapeutics Inc expected to post a loss of 66 cents a share - Earnings Preview

Reuters
·
May 06

Xilio announces new preclinical data for XTX601 at AACR

TIPRANKS
·
Apr 18

Xilio plans IND filing in 2027 for masked CLDN18.2 T-cell engager XTX601

Reuters
·
Apr 18

Xilio Therapeutics Announces Board Changes and Committee Leadership

TIPRANKS
·
Apr 16

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.d. to Its Board of Directors

THOMSON REUTERS
·
Apr 16

Press Release: Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Dow Jones
·
Apr 16

Insider Move at Xilio Therapeutics Sparks Fresh Investor Interest

TIPRANKS
·
Mar 31

Xilio director Shannon James Samuel buys USD 0.04 million common shares

Reuters
·
Mar 31

Xilio Therapeutics Inc : Leerink Partners Adjusts Target Price to $20 From $2 to Reflect 1-for-14 Reverse Stock Split

THOMSON REUTERS
·
Mar 24

Xilio Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 23

BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Cencora, Stryker

Reuters
·
Mar 23

BUZZ-Xilio rises after surprise quarterly profit

Reuters
·
Mar 23

Xilio Therapeutics Inc: Q4 Net Income USD 10.36 Million

THOMSON REUTERS
·
Mar 23

Xilio Therapeutics posts Q4 profit on higher collaboration revenue

Reuters
·
Mar 23